deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT03065244

KIDCARE (Kawasaki Disease Comparative Effectiveness Trial) (KIDCARE)

Sponsor: Patient-Centered Outcomes Research Institute

Conditions Mucocutaneous Lymph Node Syndrome
Interventions IVIG Infliximab
Updated 9 times since 2017 Last updated: Nov 5, 2021 Started: Feb 17, 2017 Primary completion: Aug 31, 2020 Completion: Nov 2, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Mucocutaneous Lymph Node Syndrome and is currently completed. Patient-Centered Outcomes Research Institute leads this study, which shows 9 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~May 2017 – ~Jun 2018 · 13 months · monthly snapshotRecruiting~Jun 2018 – ~May 2019 · 11 months · monthly snapshotRecruiting~May 2019 – ~Jan 2021 · 20 months · monthly snapshotRecruiting~Jan 2021 – ~May 2021 · 4 months · monthly snapshotRecruiting~May 2021 – ~Jan 2022 · 8 months · monthly snapshotCompleted~Jan 2022 – ~Jul 2024 · 30 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 12 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Jan 2022 — Jul 2024 [monthly]

    Completed PHASE3

  5. May 2021 — Jan 2022 [monthly]

    Completed PHASE3

    Status: Recruiting → Completed

▶ Show 4 earlier versions

  1. Jan 2021 — May 2021 [monthly]

    Recruiting PHASE3

  2. May 2019 — Jan 2021 [monthly]

    Recruiting PHASE3

  3. Jun 2018 — May 2019 [monthly]

    Recruiting PHASE3

  4. May 2017 — Jun 2018 [monthly]

    Recruiting PHASE3

    First recorded

Feb 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Patient-Centered Outcomes Research Institute
  • University of California, San Diego
Data source: University of California, San Diego

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Atlanta, United States , Aurora, United States , Birmingham, United States , Boston, United States , Chicago, United States , Columbus, United States , Dallas, United States , Detroit, United States , Houston, United States , Indianapolis, United States and 17 more locations